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Summary and Implications
       Young calves commonly become infected with viruses
and bacteria that damage the intestinal lining.  To enhance
recovery of small intestinal function following a coronavirus
challenge, bovine serum proteins, containing IgG, TGF-β
and other growth factors, were added to an oral rehydration
solution (ORS) for 32 Holstein and Jersey calves.  Calves
were housed individually and offered water ad libitum and
milk replacer at 10% of BW daily. Control calves were fed a
control ORS (CON).  The treated calves were fed an ORS
that consisted of CON with added bovine serum proteins
(GFR).   After a 2 d adjustment, calves were orally
challenged with a moderately virulent bovine coronavirus
isolate.  Xylose (0.5 g/kg of BW) was administered orally
once daily for 6 d to assess small intestinal recovery.
Hematocrits, fecal dry matter, rectal temperatures, attitude
scores and dehydration scores were recorded once daily.
Concentrations of serum xylose increased with time post-
dosing, but did not vary by treatment.  Hematocrits and
other clinical scores were not significantly different (P
>0.05) between treatments.  In this model, bovine serum
proteins did not appear to enhance intestinal recovery from a
coronavirus challenge when added to ORS.
Introduction
     Neonatal calf diarrhea is a major cause of economic loss
in the dairy industry.   Coronavirus is one of the more
common pathogens causing calf scours. Pathogens that
affect mucosal function of the intestinal tissues, such as
coronavirus, destroy villus architecture and decrease
absorptive surface area of the small intestine.  Loss of
epithelial function results in malabsorption of water,
sodium, and chloride.  Continued diarrhea increases the risk
of dehydration and hypoglycemia and, if not treated,
eventually leads to death.
When calves develop diarrhea, treatment with oral or
intravenous fluid therapy may aid in avoiding problems
such as metabolic acidosis.  In addition, oral rehydration
solutions (ORS) are formulated to maintain hydration,
replace lost electrolytes, and provide an energy source for
the diarrheic calf.  Small intestinal epithelium that has been
damaged due to pathogens is one of the most sensitive
organs to additions of growth factors.  Calves challenged
with Cryptosporidium parvum have reduced gut
permeability when dosed orally with bovine serum
concentrate containing elevated amounts of immunoglobulin
G (IgG), insulin-like growth factor-I (IGF-I), transforming
growth factor-‚ 1 (TGF-‚1) and transforming growth
factor-‚ 2 (TGF-‚ 2).    Colonic cells treated with TGF-‚ 1
before challenge with Cryptosporidium parvum maintain
their mucosal barrier as well as membrane integrity.
Therefore, the objective of this study was to enhance
the rate of recovery of small intestinal absorptive function
following a coronavirus challenge by supplementing an oral
rehydration solution with a bovine serum fraction
containing elevated levels of growth factors.
Procedures
     The trial utilized 32 Jersey and Holstein male calves (3-
5 d of age) purchased from sale barns.  Following arrival,
calves were randomized into 8 blocks of 4 calves and
weighed before being placed in individual plastic hutches
bedded with wood shavings.  Four pints of commercial
ORS were fed on arrival.  Calves were offered water ad
libitum and fed a complete (20% fat and 20% protein)
commercial milk replacer at a rate of 5% of bodyweight,
twice daily.  Feed refusals were monitored and recorded.
No hay or starter was offered.
Treatments began approximately 12 h after viral
challenge, and were provided at 10% of initial bodyweight,
twice daily, for 3 d.  Treatment one (CON) calves were fed
an oral rehydration solution formulated to include 4g/lb of
ascorbic acid (Table 1).  Treatment two (GFR) calves were
fed CON with the addition of a serum protein fraction
consisting of elevated levels of IgG, IGF-I, TGF-‚ 1 and
TGF-‚ 2 (Table 2).  Batches were mixed daily by treatment
order to minimize risk of contamination.
Fecal samples were obtained and analyzed daily for dry
matter content.  Starting on the second day, xylose was fed
orally at 0.5 g/kg of BW.  Jugular blood samples were
obtained prior to xylose feeding to provide baseline values
at time 0 and then after xylose feeding at 0.5, 1, 1.5, 2, 2.5,
3, 3.5, and 4 h.  An additional 3 cc sample of venous blood
was obtained into a heparinized tube at time 0 during
collection days and immediately analyzed for hematocrit.
Serum was separated from the sample by centrifugation at
3600 x g for 15 minutes, collected, and frozen at -20 °F for
later analysis of xylose and haptoglobin concentrations.
Xylose concentrations were determined
spectrophotometrically.  Haptoglobin was determined
spectrophotometrically using a commercial kit (TriDelta
LTD., Morris Plains).  Xylose was dosed and serial blood
samples collected on d 1, 2, 3, 4, 5, and 6.  Calves were
challenged orally with bovine coronavirus (5 x 106 plaque
forming units of a moderately virulent coronavirus isolate)
following the 4 h blood collection period on d 2.
Treatments were provided on d 3, 4, and 5.
All performance scores were evaluated and recorded daily by
a single person; these scores included fecal scores on a four-
point scale (1=firm, 2=soft, 3=runny, 4=watery), attitude
scores on a four-point scale (1=alert, 2=slightly depressed,
3=depressed, 4=laterally recumbent), dehydration scores
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using skin tent time based on a three-point scale (1=<1s,
2=2-3s, 3=>3s), and a score based on rectal temperature
(1=100-102.5, 2=<99.9, 3=>102.6).
Analysis of variance was performed using the mixed
procedures of SAS 8.1 and a model for a completely
randomized design.  The xylose data were log transformed
and sorted by treatment.  Mean values of data from days 1
and 2 prior to viral challenge were used as a covariate in the
model.  Least squares means were used to evaluate treatment
differences for xylose concentrations, performance
parameters and haptoglobin values.  Significance was
declared at P < 0.05 and trends at P < 0.15.  Treatment
means were compared using the method of least significant
differences.
Results and Discussion
     Changes in xylose concentrations (mg/dl) for calves
grouped by day are shown in Figure 1.  Treatment values
for xylose concentrations in all figures represent covariate-
adjusted least squares means.  There were no significant
differences (P > 0.05) in xylose concentrations between
treatment groups for any day post-viral challenge.
Least squares means of fecal scores were compared.
There were no significant differences between treatment
groups, although all treatment groups increased numerically
on day 2, before viral challenge.  There were no significant
differences between least squares means of fecal dry matter
between treatment groups, although dry matter was
numerically lower for all treatment groups on day 2,
correlating to the observed increase in scour scores.  There
were no significant differences in dehydration scores,
attitude scores, hematocrit or temperature between
treatments,  and  no significant differences in haptoglobin
concentrations between treatments for any time periods.
In the present study, there were no significant
differences in xylose uptake from the small intestine
between treatment groups.  Mean peak xylose concentrations
in the current study ranged from 23 to 40 mg/dl throughout
all sampling times and numerically increased following
treatments post-challenge, indicating some improvement in
gut function.  In other studies, xylose concentrations in
calves with intestinal damage peaks at 45 to 75 mg/dl.  In
healthy dogs, peak xylose concentrations range from 45 to
75 mg/dl.  Peak xylose concentrations in dogs suffering
from bacterial overgrowth in the small intestine are 30
mg/dl.  Peak xylose concentrations in the present study may
indicate the presence of bacterial overgrowth in the small
intestine, suggesting these calves were infected with
multiple pathogens prior to coronavirus challenge.
Necropsy of one calf revealed the presence of multiple
pathogens, including coronavirus, E. coli, salmonella and
clostridium.  Salmonella was not a significant source of
infection as there was no increase in rectal temperature.
Another indicator of pathogen overload was a calf mortality
rate of 24% in this study.  Although calves were challenged
with coronavirus after arrival, they were purchased from sale
barns and exposed to many pathogens prior to arrival;
infection with multiple pathogens may have severely
disrupted the absorptive and secretory mechanisms of the
intestinal tract in ways that were not compatible with the
design of the study.
Decreased intestinal absorption and prolonged diarrhea
in coronavirus challenged calves occurs as cells are sloughed
off and replaced with immature cells unable to perform
normal functions.  These immature cells are redirected due
to coronaviral infection to function only for viral
production.  Differences between treatments may have been
more evident if calves were pretreated with concentrated
serum protein fraction.  Effects of viral challenge with
Cryptosporidium parvum were ameliorated when colonic
cells were pre-treated before viral challenge with TGF-‚ 1
versus cells that were treated with TGF-‚ 1 during or after
challenge.  Cells pretreated with TGF-‚ 1 were not as
permeable as control cells and were able to better maintain
their mucosal barrier.
Serum protein fraction used in the present study
included elevated concentrations of IGF-I (1368 ng/ml),
TGF-‚ 1 (765 ng/ml), TGF-‚ 2 (9 ng/ml) and IgG (19.7%)
fractions.  Levels of IGF-I found in first-milking colostrum
range from 248 to 1850 ng/ml, while TFG-‚ 1
concentrations range from 12.4 to 42.6 ng/ml.  The serum
protein fractions were fed at 1% of BW, with total
concentration of TGF-‚ 1, for example, fed at .2754 mg
versus TGF-‚ 1 in colostrum fed at birth at .015336 mg for
a calf with an average bodyweight of 36 kg.
Immunoglobulin G may defend the intestine by preventing
the attachment of organisms, reducing their ability to
replicate and invade the gut.  Treatment with
immunoglobulins may also affect calves favorably if
infection with other enteric pathogens occurs.
Although no significant differences were seen between
treatments in the present study, many unforeseen factors
may have affected these data.  Further research needs to be
conducted to clarify effects of growth factors in response to
controlled damage to intestinal epithelium.





























Figure 1.  Changes in xylose concentrations (mg/dl) for calves grouped by day (using baseline values as a covariate).
Table 1.  Ingredient composition of control oral rehydration solution1.
Ingredient                                                      mmol/L  
Sodium    135.71
Chloride      88.01
Potassium    188.73
Dextrose          111.25
Maltodextrin    111.25
Glycine                                                             40.06
Sodium Citrate      25.33
Calcium Lactate                                                   1.92
Ascorbic Acid        2.90
1 Merrick’s, Inc., Union Center, WI
Table 2.  Ingredient composition of plasma serum fraction with elevated levels of growth factors2.
Ingredient                                       Concentration
Total protein  93.24%
Albumin  56.64%
IgG  19.70%
Moisture    3.36%
Ash    0.61%
Standard Platelet Count              600 CFU/g
Endotoxin              0.311 EU/g
TGF-‚1               765 ng/g
TGF-‚2                   9 ng/g
IGF-1 1368 ng/g
Salmonella    negative
2 APC, Inc. Ames, IA
